Skip to main content
Back to Quiet Capital

Quiet Capital's Biotechnology Portfolio

Browse 5 Biotechnology companies funded by Quiet Capital. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
5
Total Funding in Biotechnology
$351.7M

Biotechnology Portfolio Companies (5)

Export
BiotechnologyMedicalNeuroscience

Science is a clinical-stage medical technology company that develops neuroengineering systems to address neurological and sensory disorders.

Alameda, United States
March 2026
$230.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareInformation Technology

ImmuneBridge is developing allogeneic immunotherapies for cancer.

San Francisco, United States
March 2026
$7.7M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Nucleus is a new kind of genetic test designed to uncover your risks and help you have healthy kids.

New York, United States
January 2025
$14.0M
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMachine LearningMedical DevicePrecision Medicine

iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized medicine.

London, United Kingdom
October 2024
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyPetPharmaceuticalVeterinary

Loyal is a clinical-stage veterinary medicine company dedicated to extending the healthy lifespan of senior dogs.

San Francisco, United States
February 2026
$100.0M
Series C

Founder Contacts

19,000+ verified contacts

Explore Quiet Capital's Full Portfolio

View all companies funded by Quiet Capital across every industry and funding stage.

View Full Quiet Capital Portfolio